FrancophonIA/ELRC3.0 huggingface dataset:
English: It has also been shown to inhibit the growth of cultured two-cell mouse embryos and the production of progesterone in cultured human luteal cells.
Croatian: Također je pokazano da inhibira rast kultiviranih dvostaničnih embrija miševa i proizvodnju progesterona u kultiviranim ljudskim lutealnim stanicama.
English: Infants above 3 months, children and adolescents: Same posology as for adults.
Croatian: Dojenčad starija od 3 mjeseca, djeca i adolescenti: Jednako doziranje kao i za odrasle.
English: Solution for injection (injection) Clear dark blue solution with a pH value between 3.0 and 4.5 Osmolality is usually between 10 and 15 mOsm/kg.
Croatian: Otopina za injekciju (injekcija) Bistra, tamnoplava otopina pH vrijednosti između 3,0 i 4,5 Osmolalnost je obično između 10 i 15 mOsm/kg.
English: Lower doses should therefore be considered and total cumulative dose should not exceed 4 mg/kg.
Croatian: Prema tome, treba uzeti u obzir niže doze a ukupna kumulativna doza ne smije prijeći 4 mg/kg.
English: The doctor or nurse will check that the expiry date on the label has not been passed before administering the injection to you.
Croatian: Liječnik ili medicinska sestra će provjeriti rok valjanosti na naljepnici prije davanja injekcije.
English: If you have any doubts about whether this medicine should be given to you, consult your doctor.
Croatian: Ako imate bilo kakve dvojbe o tome da li Vam se ovaj lijek treba davati, obratite se svom liječniku.
English: Methylthioninium chloride Proveblue is indicated in adults, children and adolescents (aged 0 to 17 years old).
Croatian: Methylthioninium chloride Proveblue je indiciran u odraslih, djece i adolescenata (u dobi od 0 do 17 godina starosti).
English: Your doctor will inject this medicine into a vein (intravenously) slowly over a period of 5 minutes.
Croatian: Vaš liječnik će ubrizgati lijek u venu (intravenski) sporo u trajanju od 5 minuta.
English: Please refer to section 4.4 for important safety information.
Croatian: Za važne sigurnosne informacije molimo pogledajte dio 4.4.
English: The maximum recommended cumulative dose for the course of treatment is 7 mg/kg.
Croatian: Maksimalna preporučena kumulativna doza tijekom liječenja je 7 mg/kg.
English: These effects are the same in adults and children except jaundice which has only been reported in infants.
Croatian: Ove nuspojave su jednake u odraslih i u djece osim žutice koja je prijavljena samo kod dojenčadi.
English: Reproductive Toxicology
Croatian: Reproduktivna toksikologija
English: The estimated terminal half-life of methylthioninium chloride after intravenous administration is 26.7h.
Croatian: Procijenjeni terminalni poluvijek metiltioninijeva klorida nakon intravenske primjene je 26,7 h.
English: For instructions on handling and dilution of the medicinal product before administration, see section 6.6.
Croatian: Za upute o rukovanju i razrjeđivanju ovog lijeka prije primjene, vidjeti dio 6.6.
English: • Patients with Glucose-6-phosphate dehydrogenase deficiency (G6PD) due to the risk of haemolytic anaemia
Croatian: • Bolesnici koji imaju nedostatak glukoza-6-fosfat dehidrogenaze (G6PD) zbog rizika od hemolitičke anemije.
English: The majority of the dose is excreted in the urine, usually in the form of leucomethylthioninium chloride.
Croatian: Većina doze izlučuje se u mokraći, obično u obliku leukometiltioninijeva klorida.
English: Adverse reactions are the same as in adults (except hyperbilirubinaemia, reported in infants only).
Croatian: Nuspojave su iste kao i kod odraslih (osim hiperbilirubinemije koja je prijavljena samo kod dojenčadi).
English: Haemolytic anaemia has also been reported in case of severe overdose (20-30 mg/kg) in infants and adults with methaemoglobinaemia caused by aniline or chlorates.
Croatian: Hemolitička anemija također je prijavljena u slučaju teškog predoziranja (20-30 mg/kg) u dojenčadi i odraslih s methemoglobinemijom uzrokovanom anilinom ili kloratima.
English: In methaemoglobinaemia, your blood contains too much methaemoglobin (an abnormal form of haemoglobin that is not able to transport oxygen around your body effectively).
Croatian: Kod methemoglobinemije krv sadrži previše methemoglobina (abnormalan oblih hemoglobina koji ne može učinkovito prenositi kisik po Vašem tijelu).
English: The medicine must be used immediately after opening or dilution.
Croatian: Ovaj lijek se mora primijeniti odmah nakon otvaranja ili razrjeđivanja.
English: Intravenous injection of methylthioninium chloride has occasionally caused hypotension and cardiac arrhythmias, and such disorders might prove fatal on rare occasions.
Croatian: Intravenska injekcija metiltioninijeva klorida povremeno je uzrokovala hipotenziju i srčane aritmije, a takvi poremećaji mogu u rijetkim prilikama imati smrtni ishod.
English: Phototoxicity / Photosensitivity
Croatian: Nepoznato fototoksičnost/fotosenzitivnost
English: You should not be given methylthioninium chloride at the same time you are taking certain medicines to treat depression or anxiety which affect a brain chemical called serotonin.
Croatian: Ne biste trebali primiti metiltioninijev klorid ako u isto vrijeme kada uzimate i određene lijekove za liječenje depresije ili tjeskobe koji utječu na kemikaliju u mozgu koja se zove serotonin.
English: Infants 3 months old or younger
Croatian: Djeca od 3 mjeseca starosti i mlađa
English: • Hypersensitivity to the active substance, or to any other thiazine dyes
Croatian: • Preosjetljivost na djelatnu tvar ili bilo koje druge tiazinske boje
English: Indeed, driving can be affected due to confusional state, dizziness and possibly eye disturbances.
Croatian: Na sposobnost upravljanja vozilima mogu utjecati stanje konfuzije, omaglice i mogući poremećaji vida.
English: Advise patients to take protective measures against exposure to light, because photosensitivity may occur after administration of methylthioninium chloride.
Croatian: Savjetujte bolesnicima da poduzmu zaštitne mjere protiv izlaganja svjetlu, jer može doći do fotosenzitivnosti nakon primjene metiltioninijevog klorida.
English: The clinical consequences are considered likely to be minimal due to the transient and single dose use that normally occurs in the emergency setting.
Croatian: Smatra se da su kliničke posljedice vjerojatno minimalne s obzirom na prolaznu i jednokratnu upotrebu, obično u hitnim slučajevima.
English: They may appear green or blue - increased sensitivity of your skin to light (photosensitivity)
Croatian: Stolica može postati zelena ili plava - pojačana osjetljivost kože na svjetlost (fotosenzitivnost)
English: Pierrel S.p.A. s.s. Appia 7 bis, 46/48 - 81043 Capua, Italy
Croatian: Pierrel S.p.A. s.s. Appia 7 bis, 46/48 - 81043 Capua, Italija
English: Inject very slowly over a period of 5 minutes.
Croatian: Injicirati vrlo sporo u trajanju od 5 minuta.
English: The clinical consequences are however considered minimal since methylthioninium chloride Proveblue is used often only once and in an acute emergency setting.
Croatian: Međutim, smatra se da su kliničke posljedice minimalne s obzirom da se Methylthioninium chloride Proveblue često koristi samo jedanput i to u hitnim slučajevima.
English: Infants 3 months old or younger and newborn infants:
Croatian: Dojenčad u dobi od 3 mjeseca ili mlađa i novorođenčad:
English: If your blood disorder has been caused by aniline or dapsone, total cumulative dose should not exceed 4 mg/kg (see section 2).
Croatian: Ako je Vaš poremećaj krvi uzrokovan anilinom ili dapsonom, ukupna kumulativna doza ne bi smjela prijeći 4 mg/kg (vidjeti dio 2).
English: Like all medicines, Methylthioninium chloride Proveblue can cause side effects, although not everybody gets them.
Croatian: Kao i svi lijekovi, Methylthioninium chloride Proveblue može uzrokovati nuspojave iako se one neće javiti kod svakoga.
English: The efficacy of methylthioninium chloride for the treatment of methaemoglobinaemia in peadiatric population was demonstrated in two retrospective studies and one open randomised clinical trial.
Croatian: Djelotvornost metiltioninijeva klorida za liječenje methemoglobinemije u pedijatrijskoj populaciji je dokazana u dva retrospektivna ispitivanja i jednom otvorenom, randomiziranom kliničkom ispitivanju.
English: Your skin may turn blue - reduction in red blood cells which may turn your skin pale and make you breathless and weak, - jaundice (yellowing of the skin and eyes), this has only been reported in infants.
Croatian: Koža Vam može poplaviti - smanjenje broja crvenih krvnih stanica zbog čega Vaša koža može biti blijeda i što može učiniti da ostanete bez zraka i slabi - žutica (žutilo kože i očiju), prijavljena je samo kod dojenčadi.
English: Special care must be taken with Methylthioninium chloride Proveblue: - in newborns and infants 3 months old or younger, lower doses are recommended (see section 3 of this package leaflet).
Croatian: Posebna pozornost mora se obratiti na Methylthioninium chloride Proveblue: - kod novorođenčadi i dojenčadi od 3 mjeseca ili mlađe, preporučuju se niže doze (pogledajte dio
English: Pierrel S.p.A. s.s. Appia 7 bis, 46/48 IT-81043 Capua (CE) Italy
Croatian: Pierrel S.p.A. s.s. Appia 7 bis, 46/48 IT-81043 Capua (CE) Italija
English: However, if the intravenous use of methylthioninium chloride cannot be avoided, you should be administered the lowest possible dose and observed closely for up to 4 hours after administration.
Croatian: Ipak, ako se intravenska primjena metiltioninijeva klorida ne može izbjeći, treba Vam se primijeniti najmanja moguća doza i da budete pod pažljivim promatranjem do 4 sata nakon primjene.
English: If the intravenous use of methylthioninium chloride cannot be avoided in patients treated with serotonergic medicinal products, the lowest possible dose should be chosen and the patient observed closely for central nervous system (CNS) effects for up to 4 hours after administration (see sections 4.4 and 4.8).
Croatian: Ako intravensku primjenu metiltioninijeva klorida u bolesnika koji se liječe serotonergičkim lijekovima nije moguće izbjeći, potrebno je odabrati najnižu moguću dozu te je bolesnika potrebno pažljivo promatrati zbog učinaka na središnji živčani sustav (SŽS) u trajanju od 4 sata nakon primjene (vidjeti dijelove 4.4 i 4.8).
English: Serotonin Syndrome with concomitant use of serotonergic drugs (see section 4.4 and section 4.5).
Croatian: Vrlo često serotoninski sindrom prilikom istodobne uporabe serotonergičkih lijekova (vidjeti dio 4.4 i dio 4.5)
English: The adverse reactions listed in the table below occur in adults, children and adolescents (aged 0 to 17 years old) after intravenous administration.
Croatian: U sljedećoj su tablici prikazane nuspojave zabilježene u odraslih, djece i adolescenata (u dobi od 0-17 godina starosti) nakon intravenske primjene.
English: fluvoxamine, paroxetine, sertraline and zimelidine
Croatian: fluoksetin, fluvoksamin, paroksetin, sertralin i zimelidin.
English: • Common side effects (may affect up to 1 in 10 people): - stomach pain - chest pain - headache - anxiety - injection site pain - vomiting
Croatian: • Česte nuspojave (mogu se javiti u najviše 1 na 10 osoba): - bol u trbuhu - bol u prsištu - glavobolja - tjeskoba - bol na mjestu injiciranja - povraćanje
English: There are no adequate data from the use of methylthioninium chloride in pregnant women.
Croatian: Nema odgovarajućih podataka o primjeni metiltioninijeva klorida u trudnica.
English: Acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
Croatian: Akutno simptomatsko liječenje methemoglobinemije uzrokovane lijekovima i kemikalijama.
English: These include SSRIs (selective serotonin reuptake inhibitors), bupropion, buspirone, clomipramine, mirtazapine, and venlafaxine.
Croatian: Ti lijekovi uključuju SSRI-e (selektivni inhibitori ponovne pohrane serotonina), bupropion, buspiron, klomipramin, mirtazapin i venlafaksin.
English: • Selective serotonin reuptake inhibitors (SSRIs) such as citalopram, escitalopram, fluoxetine,
Croatian: • selektivne inhibitore ponovne pohrane serotonina (SSRI) kao što su citalopram, escitalopram,
English: The use of Methylthioninium chloride Proveblue during pregnancy is not recommended unless it is clearly necessary, for example in a life-threatening situation.
Croatian: Ne preporučuje se koristiti Methylthioninium chloride Proveblue tijekom trudnoće, osim ako je to neophodno potrebno, na primjer u situaciji opasnoj po život.
English: If any of the above applies to you, please consult your doctor.
Croatian: Ako se bilo što od gore navedenog odnosi na Vas, obratite se svom liječniku.
English: Methylthioninium chloride Proveblue must be injected very slowly over a period of 5 minutes to prevent high local concentrations of the compound from producing additional methaemoglobin.
Croatian: Methylthioninium chloride Proveblue mora se injicirati vrlo sporo tijekom perioda od 5 minuta da bi se spriječilo da visoke lokalne koncentracije lijeka prouzrokuju stvaranje dodatnog methemoglobina.
English: • mirtazapine
Croatian: • mirtazapin
English: • Monoamine oxidase inhibitors
Croatian: • inhibitore monoaminooksidaze
English: In the case of aniline- or dapsone-induced methaemaglobinaemia, the maximum recommended cumulative dose for the course of treatment is 4 mg/kg (see section 4.4).
Croatian: U slučaju methemoglobinemije uzrokovane anilinom ili dapsonom, maksimalna preporučena kumulativna doza tijekom cjelokupnog liječenja je 4 mg/kg (vidjeti dio 4.4).
English: Marketing Authorisation Holder Provepharm SAS
Croatian: Nositelj odobrenja za stavljanje lijeka u promet Provepharm SAS
English: In vivo, in low concentration, methylthioninium chloride speeds up the conversion of methaemoglobin to haemoglobin.
Croatian: In vivo, u niskoj koncentraciji, metiltioninijev klorid ubrzava pretvorbu methemoglobina u hemoglobin.
English: Avoid concomitant use of methylthioninium chloride with selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (see section 4.5).
Croatian: Izbjegavajte istodobnu uporabu metiltioninijevog klorida sa selektivnim inhibitorima ponovne pohrane serotonina (SSRI), inhibitorima ponovne pohrane serotonina i noradrenalina (SNRI) te inhibitorima monoaminooksidaze (vidjeti dio 4.5).
English: Due to a lack of available data on whether methylthioninium chloride passes into human breast milk, breast-feeding should be discontinued for up to 8 days after treatment with this medicine.
Croatian: Zbog nepostojanja dostupnih podataka izlučuje li se metiltioninijev klorid u majčino mlijeko u ljudi, dojenje treba prekinuti do 8 dana nakon prestanka liječenja ovim lijekom.
English: For storage conditions of the diluted medicinal product, see section 6.3.
Croatian: Za uvjete čuvanja razrijeđenog lijeka, vidjeti dio 6.3.
English: Solution for injection 5 ampoules of 10 ml
Croatian: Otopina za injekciju 5 ampula od 10 ml
English: Some evidence of carcinogenic activity of methylthioniniul chloride has been shown in male mice and male rats.
Croatian: Pokazani su neki dokazi kancerogene aktivnosti metiltioninijeva klorida u muških miševa i muških štakora.
English: The maximum recommended cumulative dose for the course of treatment is 7 mg/kg and should not be exceeded, since Methylthioninium chloride administered above the maximum dose may cause methaemoglobinaemia in susceptible patients.
Croatian: Maksimalna preporučena kumulativna doza tijekom liječenja je 7 mg/kg i ne smije se prekoračiti jer metiltioninijev klorid primijenjen iznad maksimalne doze lijeka kod podložnih bolesnika može uzrokovati methemoglobinemiju.
English: The most commonly reported adverse reactions observed during clinical trials are dizziness, paraesthesia, dysgeusia, nausea, skin discoloration, chromaturia, sweating, injection site pain and pain in extremity.
Croatian: Najčešće prijavljene nuspojave zabilježene u kliničkim ispitivanjima su omaglica, parestezije, disgeuzija, mučnina, promjena boje kože, kromaturija, znojenje, bol na mjestu injiciranja i bol u ekstremitetu.
English: If symptoms of serotonin syndrome occur, discontinue use of methylthioninium chloride, and initiate supportive treatment.
Croatian: Ako dođe do pojave simptoma serotoninskog sindroma, prekinite uporabu metiltioninijevog klorida i započnite potporno liječenje.
English: Do not drive or use any tools or machines as methylthioninium chloride has moderate influence on the ability to drive and use machines.
Croatian: Nemojte upravljati vozilima i strojevima jer metiltioninijev klorid ima umjereni utjecaj na sposobnost upravljanja vozilima i strojevima.
English: Methylthioninium chloride (also called methylene blue) belongs to a group of medicines called antidotes.
Croatian: Metiltioninijev klorid (koji se još naziva i metilensko plavilo) pripada grupi lijekova koji se zovu protuotrovi.
English: Methylthioninium chloride may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs.
Croatian: Metiltioninijev klorid može izazvati ozbiljan ili fatalan serotoninski sindrom kada se koristi u kombinaciji sa serotonergičkim lijekovima.
English: Methylthioninium chloride Proveblue will be given to you or your child (0-17 years old) to treat problems with your blood resulting from exposure to some medicines or chemicals that can cause a disease called methaemoglobinaemia.
Croatian: Vi ili Vaše dijete (0-17 godina starosti) ćete dobiti Methylthioninium chloride Proveblue za liječenje problema s krvi koji proizlaze iz izlaganja nekim lijekovima ili kemikalijama koje mogu uzrokovati bolest koja se zove methemoglobinemija.
English: - if you suffer from hyperglycaemia or diabetes mellitus, as these conditions may be worsened by the glucose solution used for the dilution of the medicine - your urine and stools may turn a blue-green colour; and skin may possibly turn a blue colour when you are treated with Methylthioninium chloride Proveblue.
Croatian: - ako bolujete od hiperglikemije ili šećerne bolesti, jer otopina glukoze koja se koristi za razrjeđivanje lijeka može pogoršati ova stanja - Vaša mokraća i stolica mogu postati plavo-zelene boje i koža može poplaviti kada se liječite lijekom Methylthioninium chloride Proveblue.
English: The clinical consequences of increases plasma concentration of co-administered drugs which are sensitive CYP 1A2, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A substrates cannot be ruled out.
Croatian: Nije moguće isključiti kliničke posljedice povećanja plazmatske koncentracije istodobno primijenjenih lijekova koji su osjetljivi supstrati CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 i 3A.
English: Your skin may turn blue blue or green urine numbness and tingling abnormal taste in mouth nausea
Croatian: Koža vam može poplaviti - plava ili zelena mokraća - utrnulost i trnci - abnormalan okus u ustima - mučnina
English: The administration of large intravenous doses (≥ 7 mg/kg) of Methylthioninium chloride Proveblue to individuals without methaemoglobinaemia induces nausea and vomiting, chest tightness, chest pain, tachycardia, apprehension, severe sweating, tremor, mydriasis, blue-green staining of the urine, blue staining of the skin and mucous membranes, abdominal pain, dizziness, paraesthesia, headache, confusion, hypertension, mild methaemoglobinaemia (up to 7%) and electrocardiogram changes (T wave flattening or inversion).
Croatian: Primjena velikih intravenskih doza (≥ 7 mg/kg) lijeka Methylthioninium chloride Proveblue u osoba bez methemoglobinemije izaziva mučninu i povraćanje, stezanje u prsištu, bol u prsištu, tahikardiju, strah, jako znojenje, tremor, midrijazu, plavo-zelenu obojenost mokraće, plavo obojenje kože i sluznica, bol u abdomenu, omaglicu, paresteziju, glavobolju, konfuziju, hipertenziju, blagu methemoglobinemiju (do 7%) i promjene na elektrokardiogramu (ravnanje ili inverziju T vala).
English: The excretion of methylthioninium chloride in milk has not been studied in animals.
Croatian: Izlučivanje metiltioninijeva klorida u mlijeko nije ispitivano na životinjama.
English: Methylthioninium chloride was mutagenic in gene mutation assays in bacteria and mouse lymphoma cells but not in vivo mouse micronucleus assay when administered intravenously at 62 mg/kg.
Croatian: Metiltioninijev klorid je bio mutagen u testovima mutacije gena u bakterija i stanicama limfoma miševa, ali ne i na in vivo mikronukleusnom testu miševa kod intravenske primjene 62 mg/kg.
English: • clomipramine
Croatian: • klomipramin
English: 52, Rue Marcel et Jacques Gaucher 94120 Fontenay-sous-Bois France
Croatian: 52, Rue Marcel et Jacques Gaucher 94120 Fontenay-sous-Bois Francuska
English: Too limited data are available to support a continuous infusion dose recommendation.
Croatian: Za preporuku doze za kontinuiranu infuziju ne postoji dovoljno dostupnih podataka.
English: It imparts a blue-green colour to urine, faeces and a blue colour to skin which may hinder a diagnosis of cyanosis.
Croatian: Uzrokuje plavo-zelenu boju mokraće, stolice te plavu boju kože zbog koje može onemogućiti dijagnosticiranje cijanoze.
English: Based on kinetic data, breast-feeding should be discontinued for up to 8 days after treatment with Methylthioninium chloride Proveblue.
Croatian: Na temelju kinetičkih podataka, dojenje treba prekinuti do 8 dana nakon prestanka liječenja lijekom Methylthioninium chloride Proveblue.
English: 5 ampoules of 2 ml 20 ampoules of 2 ml 10 mg/2 ml
Croatian: 5 ampula od 2 ml 20 ampula od 2 ml 10 mg/2 ml
English: Extreme caution should be exercised when administering to newborns and infants below the age of 3 months due to lower concentrations of NADPH-methaemoglobin reductase necessary for reducing methaemoglobin to haemoglobin, making these infants more susceptible to methaemoglobinaemia produced by high doses of methylthioninium chloride.
Croatian: Nužan je izraziti oprez pri primjeni u novorođenčadi i dojenčadi mlađe od 3 mjeseca zbog nižih koncentracija NADPH-methemoglobin reduktaze potrebne za redukciju methemoglobina u hemoglobin, zbog čega je dojenčad podložnija methemoglobinemiji uzrokovanoj visokim dozama metiltioninijeva klorida.
English: You should not be given this medicine after the expiry date which is printed on the carton and the ampoule labels after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnicama ampule iza „Rok valjanosti“ ili „EXP“.
English: Methylthioninium chloride should be avoided in patients receiving medicinal products that enhance serotonergic transmission because of the potential for serious CNS reactions, including potentially fatal serotonin syndrome.
Croatian: Metiltioninijev klorid trebaju izbjegavati bolesnici koji primaju lijekove koji pojačavaju serotonergički prijenos zbog potencijalnih ozbiljnih reakcija SŽS-a, uključujući potencijalno fatalni serotoninski sindrom.
English: Methylthioninium chloride Proveblue can exacerbate dapsone-induced haemolytic anemia because of the formation of the dapsone reactive metabolite hydroxylamine which oxidises haemoglobin.
Croatian: Methylthioninium chloride Proveblue može pogoršati hemolitičku anemiju izazvanu dapsonom zbog stvaranja reaktivnog metabolita dapsona hidroksilamina, koji oksidira hemoglobin.
English: Preparation for intravenous administration
Croatian: Priprema za intravensku primjenu
English: Patients with hyperglycaemia or diabetes mellitus
Croatian: Bolesnici s hiperglikemijom ili šećernom bolesti
English: What Methylthioninium chloride Proveblue is and what it is used for What you need to know before you are given Methylthioninium chloride Proveblue How Methylthioninium chloride Proveblue is given Possible side effects
Croatian: Što je Methylthioninium chloride Proveblue i za što se koristi Što morate znati prije nego primite Methylthioninium chloride Proveblue Kako primjenjivati Methylthioninium chloride Proveblue Moguće nuspojave
English: Methylthioninium chloride is an in vitro inhibitor of CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 and 3A4/5.
Croatian: Metiltioninijev klorid je in vitro inhibitor CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6 i 3A4/5.
English: How to store Methylthioninium chloride Proveblue Contents of the pack and other information
Croatian: Kako čuvati Methylthioninium chloride Proveblue Sadržaj pakiranja i druge informacije